Narjust Florez, Co-Director of Young Lung Cancer Program at Dana-Farber Cancer Institute, shared a post on X:
“One of the most important questions in oncology is not just how we treat cancer, but how we detect it earlier.
Studies like this highlight the power of collaboration, patient participation, and translational research in shaping the future of cancer care.”
Title: A Longitudinal Comprehensive Biospecimen and Clinical Data Repository for Cancer Early Detection: The InAdvance Study
Authors: Tia L. Kauffman, Elizabeth K. O’Donnell, Catherine R. Marinac, Ana Babic, Kareem Adams, Jenna B. Beckwith, Tara A. Berman, Kristen D. Brantley, Dipanjan Chowdhury, Brian D. Crompton, Lisa R. Diller, Kevin M. Elias, Colleen M. Feltmate, Narjust Florez, Judy E. Garber, Irene Ghobrial, Glenn J. Hanna, Sahand Hormoz, Junne Kamihara, Nicole R. LeBoeuf, Elizabeth A. Mittendorf, Ann H. Partridge, Nicolette J. Rodriguez, Jacob Sands, Bicky Thapa, Lachelle D. Weeks, Sook-Bin Woo, Matthew B. Yurgelun, Giovanni Parmigiani, Timothy R. Rebbeck, Sapna Syngal
Other articles featuring Narjust Florez on OncoDaily.
